Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-13-039860

Options or other derivatives

  • Chief Executive Officer bought 1 shares
  • Chief Executive Officer acquired 1,650,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Chan Phillip P. Chief Executive Officer 2013-06-21 Purchase · Convertible Note +0 $50,000.00 $0 D: show line 1 in the form
Chan Phillip P. Chief Executive Officer 2013-06-21 Purchase · Warrants +1 1 D: show line 2 in the form
Chan Phillip P. Chief Executive Officer 2013-04-04 Grant or award · Stock Option +1,650,000 8,113,042 D: show line 3 in the form
Loading xslF345X03/v347190_form4.xml…